Not available
Quote | Ascendis Pharma A/S (NASDAQ:ASND)
Last: | $140.17 |
---|---|
Change Percent: | -0.35% |
Open: | $141.39 |
Close: | $140.17 |
High: | $144.41 |
Low: | $137.78 |
Volume: | 270,427 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Ascendis Pharma A/S (NASDAQ:ASND)
2024-04-19 17:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-07 06:30:00 ET Summary ProfoundBio, a Seattle ADC company with an R&D facility in Suzhou, will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. China Medical System in-licensed povorcitinib, an oral JAK1 inhibitor, from San Franciscoȁ...
Message Board Posts | Ascendis Pharma A/S (NASDAQ:ASND)
Subject | By | Source | When |
---|---|---|---|
Short today at 85.34 | MiamiGent | investorshub | 05/01/2023 8:42:43 PM |
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric | crudeoil24 | investorshub | 08/25/2021 9:19:58 PM |
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, | crudeoil24 | investorshub | 08/25/2021 9:17:30 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-19 17:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 15 years by 17.87% on an annualized basis producing an average annual retur...
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 44.46% on an annualized basis producing an average annual retur...